Regarding Global Failings
A couple of you, including myself, wondered if SNDY sales reflected a failure by the same to penetrate the world market.
I returned to old artifacts gathered during my DD. I ran across the following that makes me deduce--albeit a tenuous deduction--that SNDY only now, in 2012, attempts to penetrate the world market.
The article is from Feb of last year. The SNDY president clearly identifies a thrust into the "domestic market", never alluding to global intent.
"Solos' focus is to strengthen its domestic market share in the industry through the implementation of several strategies and the addition of new product lines throughout 2011."
--Healthcare Sales and Marketing Network
So, it is my "opinion" that SNDY (2011) worked to better establish itself domestically (and the positive of last year is its endoscopy line inching forward in the medical field) and now, in 2012, SNDY is working to establish itself globally.
Today, the stage is world wide for SNDY. If that stage, at the end of the year, exposes weak ticket sales, then my DD did not pay off. I and others on this board think ticket sales will increase.
SNDY is working to reclaim, regain momentum and from that grow sales. This year, I will watch QTRLY filings and hopefully see their stated goal occurring.
For several weeks, some on this board have written that SNDY will get CE mark in a matter of weeks. In hindsight, we know now that didn't happen. I have expressed that CE mark completion may be much further down the line. My point: the global aspect of SNDY won't be evaluated until after CE mark completed and opportunity presented for sales generation. Realistically, I am compelled to stand as a long in this stock (I don't have time to track stocks daily...flipper).
I believe the SNDY president is the right man for the job. He seems to be making the right calls and showing signs that he cares about investors. SNDY improved their product line in quality and quantity and commits money to R&D to pursue further improvement.
Like so many on this board have stated, look to management, look to the insiders...our bet is on SNDY management and their ability to exploit their quality products.
All in my opinion. Thank you for forcing me to review my notes. As a result, I am more confident that SNDY will succeed. I just won't, at this point, claim SNDY can be $1 or $2 dollars per share as some on this board claim. I see a much smaller, but significant PPS improvement that provides each investor a handsome return on their investment.
Good fortune to all.
AI
